Past, present, and future climate space of the only endemic vertebrate genus of the Italian peninsula
Ontology highlight
ABSTRACT:
SUBMITTER: Macaluso L
PROVIDER: S-EPMC8590061 | biostudies-literature |
REPOSITORIES: biostudies-literature
Similar Datasets
Project description:A forecast of nuisance flooding of Charleston peninsula is presented, based on an analysis of tide records from Charleston Harbor, SC. The forecast was based on past trends in local sea level and tidal harmonics, including the 18.6-yr lunar nodal and annual cycles. The data document an exponential rise in mean sea level. Extrapolating to year 2060 shows that the sea-level trend already is equivalent to the RCP4.5 scenario and on track to exceed NOAA's intermediate low sea-level rise scenario of 0.5 m this century. If the trend continues, MSL will have risen by 0.22 m in 50 yr at an annual rate of 0.5 cm/yr in 2069. Simulations to 2064-2068, based on an empirical relationship between the annual number of flood events, defined as a water level exceeding 1.17 m NAVD (North American Vertical Datum of 1988), and the annual sum of monthly mean high water (r2 = 0.84), predict annual flood events will rise to the 60 to 75 range. Application of the hourly tidal harmonics to the long-term sea-level trend provided estimates of total land area flooded and duration of flooding. Flood duration is expected to rise to 6.5% by 2046-2050 and 8.2% of time by 2064-2068. The area exposed to flooding will be 4.23 km2 in 2046-2050 and 4.46 km2 in 2064-2068, corresponding to about 20-21% of peninsular area on what was formerly marshland and creeks, filled in earlier centuries. Finally, the estimated cost of defending the city and a proposal for a climate tax are discussed.
| S-EPMC7500608 | biostudies-literature
Project description:Climate change is expected to increase global mean temperatures leading to higher tropospheric ozone (O3) concentrations in already polluted regions, potentially eroding the benefits of expensive emission controls. The magnitude of the "O3-climate penalty" has generally decreased over the past three decades, which makes future predictions for climate impacts on air quality uncertain. Researchers attribute historical reductions in the O3-climate penalty to reductions in NOx emissions but have so far not extended this theory into a quantitative prediction for future effects. Here, we show that a three-dimensional air quality model can be used to map the behavior of the O3-climate penalty under varying NOx and VOC emissions in both NOx-limited and NOx-saturated conditions in Central and Southern California, respectively. Simulations suggest that the planned emissions control program for O3 precursors will not diminish the O3-climate penalty to zero as some observational studies might imply. The results further demonstrate that in a NOx-limited air basin, NOx control strategies alone are sufficient to both decrease the O3-climate penalty and mitigate O3 pollution, while in a NOx-saturated air basin, a modified emissions control plan that carefully chooses reductions in both NOx and VOC emissions may be necessary to eliminate the O3-climate penalty while simultaneously reducing base case O3 concentrations to desired levels. Additional modeling is needed to determine the behavior of the O3-climate penalty as NOx and VOC emissions evolve in other regions.
| S-EPMC3990462 | biostudies-literature
Project description:The evolution of biocrystallography from the pioneers' time to the present era of global biology is presented in relation to the development of methodological and instrumental advances for molecular sample preparation and structure elucidation over the last 6 decades. The interdisciplinarity of the field that generated cross-fertilization between physics- and biology-focused themes is emphasized. In particular, strategies to circumvent the main bottlenecks of biocrystallography are discussed. They concern (i) the way macromolecular targets are selected, designed, and characterized, (ii) crystallogenesis and how to deal with physical and biological parameters that impact crystallization for growing and optimizing crystals, and (iii) the methods for crystal analysis and 3D structure determination. Milestones that have marked the history of biocrystallography illustrate the discussion. Finally, the future of the field is envisaged. Wide gaps of the structural space need to be filed and membrane proteins as well as intrinsically unstructured proteins still constitute challenging targets. Solving supramolecular assemblies of increasing complexity, developing a "4D biology" for decrypting the kinematic changes in macromolecular structures in action, integrating these structural data in the whole cell organization, and deciphering biomedical implications will represent the new frontiers.
| S-EPMC2929629 | biostudies-literature
Project description:BackgroundGLUT1 deficiency syndrome is a rare, genetically determined neurological disorder for which Ketogenic Dietary Treatment represents the gold standard and lifelong treatment. Patient registries are powerful tools providing insights and real-world data on rare diseases.ObjectiveTo describe the implementation of a national web-based registry for GLUT1-DS.MethodsThis is a retrospective and prospective, multicenter, observational registry developed in collaboration with the Italian GLUT1-DS association and based on an innovative, flexible and configurable cloud computing technology platform, structured according to the most rigorous requirements for the management of patient's sensitive data. The Glut1 Registry collects baseline and follow-up data on the patient's demographics, history, symptoms, genotype, clinical, and instrumental evaluations and therapies.ResultsFive Centers in Italy joined the registry, and two more Centers are currently joining. In the first two years of running, data from 67 patients (40 females and 27 males) have been collected. Age at symptom onset was within the first year of life in most (40, 60%) patients. The diagnosis was formulated in infancy in almost half of the cases (34, 51%). Symptoms at onset were mainly paroxysmal (mostly epileptic seizure and paroxysmal ocular movement disorder) or mixed paroxysmal and fixed symptoms (mostly psychomotor delay). Most patients (53, 79%) are currently under Ketogenic dietary treatments.ConclusionsWe describe the principles behind the design, development, and deployment of the web-based nationwide GLUT1-DS registry. It represents a stepping stone towards a more comprehensive understanding of the disease from onset to adulthood. It also represents a virtuous model from a technical, legal, and organizational point of view, thus representing a possible paradigmatic example for other rare disease registry implementation.
| S-EPMC10029278 | biostudies-literature
Project description:The uses of antiviral agents are increasing in the new era along with the development of vaccines for the effective control of viral diseases. The main aims of antiviral agents are to minimize harm to the host system and eradicate deadly viral diseases. However, the replications of viruses in host system represent a massive therapeutic challenge than bacteria and fungi. Antiviral drugs not just penetrate to disrupt the virus’ cellular divisions but also have a negative impact on normal physiological pathways in the host. Due to these issues, antiviral agents have a narrow therapeutic index than antibacterial drugs. Nephrotoxicity is the main adverse reaction of antiviral drugs in human and animals. In this chapter, we summarize the antiviral agents’ past, present and future perspectives with the main focus on the brief history of antiviral in animals, miscellaneous drugs, natural products, herbal and repurposing drugs.
| S-EPMC7120554 | biostudies-literature
Project description:The terminal differentiation of the epidermis is a complex physiological process. During the past few decades, medical genetics has shown that defects in the stratum corneum (SC) permeability barrier cause a myriad of pathological conditions, ranging from common dry skin to lethal ichthyoses. Contrarily, molecular phylogenetics has revealed that amniotes have acquired a specialized form of cytoprotection cornification that provides mechanical resilience to the SC. This superior biochemical property, along with desiccation tolerance, is attributable to the proper formation of the macromolecular protein-lipid complex termed cornified cell envelopes (CE). Cornification largely depends on the peculiar biochemical and biophysical properties of loricrin, which is a major CE component. Despite its quantitative significance, loricrin knockout (LKO) mice have revealed it to be dispensable for the SC permeability barrier. Nevertheless, LKO mice have brought us valuable lessons. It is also becoming evident that absent loricrin affects skin homeostasis more profoundly in many more aspects than previously expected. Through an extensive review of aggregate evidence, we discuss herein the functional significance of the thiol-rich protein loricrin from a biochemical, genetic, pathological, metabolic, or immunological aspect with some theoretical and speculative perspectives.
| S-EPMC7177664 | biostudies-literature
Project description:In this review, we summarize the current "state of the art" of carbapenem antibiotics and their role in our antimicrobial armamentarium. Among the ?-lactams currently available, carbapenems are unique because they are relatively resistant to hydrolysis by most ?-lactamases, in some cases act as "slow substrates" or inhibitors of ?-lactamases, and still target penicillin binding proteins. This "value-added feature" of inhibiting ?-lactamases serves as a major rationale for expansion of this class of ?-lactams. We describe the initial discovery and development of the carbapenem family of ?-lactams. Of the early carbapenems evaluated, thienamycin demonstrated the greatest antimicrobial activity and became the parent compound for all subsequent carbapenems. To date, more than 80 compounds with mostly improved antimicrobial properties, compared to those of thienamycin, are described in the literature. We also highlight important features of the carbapenems that are presently in clinical use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem. In closing, we emphasize some major challenges and urge the medicinal chemist to continue development of these versatile and potent compounds, as they have served us well for more than 3 decades.
| S-EPMC3195018 | biostudies-literature
Project description: Not available
| S-EPMC2194748 | biostudies-literature
Project description:Integrons are versatile gene acquisition systems commonly found in bacterial genomes. They are ancient elements that are a hot spot for genomic complexity, generating phenotypic diversity and shaping adaptive responses. In recent times, they have had a major role in the acquisition, expression, and dissemination of antibiotic resistance genes. Assessing the ongoing threats posed by integrons requires an understanding of their origins and evolutionary history. This review examines the functions and activities of integrons before the antibiotic era. It shows how antibiotic use selected particular integrons from among the environmental pool of these elements, such that integrons carrying resistance genes are now present in the majority of Gram-negative pathogens. Finally, it examines the potential consequences of widespread pollution with the novel integrons that have been assembled via the agency of human antibiotic use and speculates on the potential uses of integrons as platforms for biotechnology.
| S-EPMC4054258 | biostudies-literature
Project description:In recent years, Bruton tyrosine kinase (BTK) inhibitors have provided significant advances in the treatment of patients with B-cell malignancies. Ibrutinib was the first BTK inhibitor to be approved, and it changed the standard-of-care treatment for diseases such as chronic lymphocytic leukemia, mantle cell lymphoma, marginal zone lymphoma, and Waldenström macroglobulinemia, improving efficacy outcomes and safety compared to chemotherapy. In this article, we review the development of zanubrutinib, a next-generation BTK inhibitor, from molecular design to patient-related outcomes. We start this journey by providing insights into the discovery of BTK and the physiologic, genetic, and molecular characterization of patients lacking this kinase, together with the brief treatment landscape in the era of chemo-immunotherapies. Zanubrutinib was originally developed by applying a structure-activity strategy to enhance the specificity as well as enzymatic and pharmacokinetic properties. Preclinical studies confirmed greater specificity and better bioavailability of zanubrutinib compared with that of ibrutinib, which supported the initiation of clinical trials in humans. Preliminary clinical results indicated activity in B-cell malignancies together with an improved safety profile, in line with less off-target effects described in the preclinical studies. The clinical program of zanubrutinib has since expanded significantly, with ongoing studies in a wide range of hemato-oncological diseases and in combination with many other therapies. Zanubrutinib currently is approved for various B-cell malignancies in multiple countries. This story highlights the importance of multidisciplinary collaborative research, from bench to bedside, and provides an example of how the commitment to finding improved treatment options should always run parallel to patient care.
| S-EPMC10495438 | biostudies-literature